Background Giant cell tumor of bone (GCTB) is an aggressive benign bone tumor with poor prognosis whose neoplastic component is stromal cells (SCs). Tumor stem-like cells (TSCs) have been demonstrated as precursors for tumor genesis and growth. The aim of this study is to identify TSCs in GCTB. Methods Stro-1+ and Stro-1- cells were isolated by fluorescence-activated cell sorting (FACS). Stem-like properties of both Stro-1+ and Stro-1- subpopulations were assessed using MTT colorimetric assays, cell cycle analyses, sphere formation assays, and differentiation assays. Molecular profiles were analyzed by flow cytometry, immunofluorescence, and qRT-PCR. Results The existence of rare Stro-1 + cells was confirmed in vitro using FACS and in vivo by immunohistochemistry. These Stro-1+ cells exhibited higher proliferative and cisplatin-resistant potentials than Stro-1- cells. In serum-free suspension cultures, Stro-1+ SCs could form cell spheres and maintain self-renewal. Furthermore, Stro-1+ SCs could differentiate into two mesenchymal lineage cells: osteoblasts and adipocytes. Cell surface markers CD44, CD117, and CD133 and stem cell-associated genes OCT3/4, NANOG, and ABCG2 were significantly higher in the Stro-1+ subpopulation. Conclusions This study demonstrates that Stro-1+ SCs in GCTB possess stem-like biological and molecular phenotypes, indicating that they are the TSCs of GCTB. J. Surg. Oncol. 2012; 106:826-836. © 2012 Wiley Periodicals, Inc. Copyright © 2012 Wiley Periodicals, Inc.
CITATION STYLE
Lan, J., Liu, X., Rong, W., Wei, F., Jiang, L., Yu, H., … Liu, Z. (2012). Stro-1+ stromal cells have stem-like features in giant cell tumor of bone. Journal of Surgical Oncology, 106(7), 826–836. https://doi.org/10.1002/jso.23151
Mendeley helps you to discover research relevant for your work.